Rebecka Bergström

About me

Bioinformatician in cancer genomics. Works with DNA analysis in multiple
large, prospective, clinical studies to find patient specific mutation
profiles which can be the basis for personalized treatment.

Article: BRITISH JOURNAL OF CANCER. 2023;128(4):678-690

Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma.

Murumägi A; Ungureanu D; Khan S; Arjama M; Välimäki K; Ianevski A; Ianevski P; Bergström R; Dini A; Kanerva A; Koivisto-Korander R; Tapper J; Lassus H; Loukovaara M; Mägi A; Hirasawa A; Aoki D; Pietiäinen V; Pellinen T; Bützow R; Aittokallio T; Kallioniemi O
Article: PROSTATE. 2022;82(5):576-583

Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin.

Lindh C; Samaratunga H; Delahunt B; Bergström R; Chellappa V; Yaxley J; Lindberg J; Egevad L
Article: PROSTATE. 2019;79(8):920-928

Somatic alterations detected in diagnostic prostate biopsies provide an inadequate representation of multifocal prostate cancer.

Kristiansen A; Bergström R; Delahunt B; Samaratunga H; Guðjónsdóttir J; Grönberg H; Egevad L; Lindberg J